Drug repurposing in oncology - Authors' reply

Lancet Oncol. 2020 Dec;21(12):e544. doi: 10.1016/S1470-2045(20)30692-6.

Authors

Audrey A Tran¹, Vinay Prasad²

Affiliations

¹ School of Medicine and Division of Hematology Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
² Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA 94158, USA. Electronic address: vinayak.prasad@ucsf.edu.

PMID: 33271101
DOI: 10.1016/S1470-2045(20)30692-6

No abstract available

Publication types

Letter
Comment

MeSH terms

Drug Repositioning*
Humans
Medical Oncology
Neoplasms*